M MINARIS
LIVE

Serial Number

99591689

Owner

MINARIS ADVANCED THERAPIES, LLC

Attorney

KATE SHERLOCK

First Use Date

May 31, 2025

Filing Date

Jan 13, 2026

Add to watchlist:

No watchlists yet
View on USPTO

M MINARIS Trademark

Serial Number: 99591689

M MINARIS is a trademark filed by MINARIS ADVANCED THERAPIES, LLC on January 13, 2026. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

MINARIS ADVANCED THERAPIES, LLC

400 Rouse Blvd.
Philadelphia, PA 19112

Entity Type: 16

Trademark Details

Filing Date

January 13, 2026

Registration Date

Not Registered

First Use Anywhere

May 31, 2025

First Use in Commerce

May 31, 2025

Published for Opposition

June 16, 2026

Goods & Services

Contract manufacturing in the nature of biomanufacturing for others of pharmaceuticals using biological cells in the manufacturing process; Providing information, advice and consultancy in the field of contract manufacturing in the nature of biomanufacturing for others of pharmaceuticals using biological cells in the manufacturing process.

Information, advice and consultancy services relating to medical services and regenerative medicine; human tissue bank services; providing medical information; collection and preservation of human blood; medical, medicinal and pharmaceutical consultancy

Pharmaceutical research and development services, namely, contracted cell culturing and tissue culturing for scientific purposes; scientific and technological services, namely, testing, inspection for quality control purposes, and research in the field of cell culture and tissue culture, and consultancy and information services relating thereto; pharmaceutical research and development advisory services, namely, advisory services in the field of cell culturing for scientific purposes; research and product development services in the field of cell culture and tissue culture, and consultancy relating thereto; scientific consulting and research services relating to the isolation and cultivation of body tissues and cells; advisory services for pharmaceutical drug development; scientific testing and research services in the field of pharmaceuticals and biotechnology, and advisory services relating thereto; contracted development of biological cell culturing processes; scientific laboratory services, namely, the cultivation or modification of hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration into living drugs; quality control of goods and services in the field of cell and tissue culturing, and consultancy relating thereto; quality control of goods in the nature of biological cells and living tissue for others; Scientific laboratory services relating to the isolation and cultivation of body tissues and cells for medical purposes, contracted cell culturing and tissue culturing for medical purposes, and advisory services in the field of contracted cell culturing and tissue culturing for medical purposes.

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 14, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2026 CNRT
ASSIGNED TO EXAMINER
May 11, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 1, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 13, 2026 MAFR
NEW APPLICATION ENTERED
Jan 13, 2026 NWAP